Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
06 2020
Historique:
received: 21 11 2019
revised: 29 01 2020
accepted: 10 02 2020
pubmed: 24 2 2020
medline: 24 6 2021
entrez: 24 2 2020
Statut: ppublish

Résumé

Peripheral blood stem cells (PBSCs) have been increasingly used for allogeneic hematopoietic cell transplantation instead of bone marrow stem cells. Current National Marrow Donor Program policy recommends 5 days of daily filgrastim, followed by either 1 or 2 days of apheresis for unrelated donors, depending on collection center choice. To date, there are no published studies comparing the differences in donor experience between 1 day and 2 days of apheresis. We examined 22,348 adult unrelated donor collections in 184 centers between 2006 and 2016. Of these 22,348 donors, 20,004 (89.5%) had collection on 1 day, and the other 2344 (9.5%) had collection over 2 days. Information on why donors underwent apheresis in 1 day or 2 days was not available. Donors who underwent apheresis in 1 day were more likely to be male (67% versus 46%; P < .001), younger (age <30 years, 48% versus 36%; P < .001), and have a higher body weight (83.0 kg versus 75.9 kg; P< .001) and body mass index (BMI; >30, 30% versus 22%; P < .001). Successful collection of the requested CD34

Identifiants

pubmed: 32088366
pii: S1083-8791(20)30096-3
doi: 10.1016/j.bbmt.2020.02.011
pmc: PMC7347029
mid: NIHMS1589932
pii:
doi:

Substances chimiques

Antigens, CD34 0
Granulocyte Colony-Stimulating Factor 143011-72-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1210-1217

Subventions

Organisme : NCI NIH HHS
ID : U24 CA076518
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Références

Blood. 1995 Mar 15;85(6):1659-65
pubmed: 7888684
J Clin Apher. 1999;14(1):18-25
pubmed: 10355659
Br J Haematol. 2003 Mar;120(5):801-7
pubmed: 12614213
Blood. 2009 Oct 29;114(18):3757-63
pubmed: 19666868
J Clin Apher. 2003;18(1):10-5
pubmed: 12717787
Blood. 1995 Mar 15;85(6):1655-8
pubmed: 7534140
Blood. 2014 Jun 5;123(23):3655-63
pubmed: 24735965
Blood. 2009 Apr 9;113(15):3604-11
pubmed: 19190248
Bone Marrow Transplant. 2001 Apr;27(7):689-92
pubmed: 11360107
Transfusion. 2000 Nov;40(11):1363-70
pubmed: 11099666
Transfusion. 2000 Apr;40(4):493-5
pubmed: 10773065
Haematologica. 2009 Jan;94(1):94-101
pubmed: 19059940
Vox Sang. 2005 Nov;89(4):229-35
pubmed: 16262756
Nature. 2008 Mar 27;452(7186):442-7
pubmed: 18256599
Blood. 2013 Jan 3;121(1):197-206
pubmed: 23109243
Blood. 1995 Mar 15;85(6):1666-72
pubmed: 7534141
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S1-S2
pubmed: 18724277
Transfusion. 1999 Apr;39(4):403-9
pubmed: 10220268
Cell Stem Cell. 2008 Oct 9;3(4):364-6
pubmed: 18940728

Auteurs

Jack W Hsu (JW)

Division of Hematology and Oncology, College of Medicine, University of Florida, Gainesville, Florida. Electronic address: hsujw@medicine.ufl.edu.

Bronwen E Shaw (BE)

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Soyoung Kim (S)

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.

Brent R Logan (BR)

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.

Jennifer A Sees (JA)

Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Dennis L Confer (DL)

Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota; National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Michael A Pulsipher (MA)

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California.

Nirali Shah (N)

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Galen E Switzer (GE)

University of Pittsburgh Medical Center- Cancer Center University of Pittsburgh, Pittsburgh, Pennsylvania.

Muneer H Abidi (MH)

Hematology and Oncology, Spectrum Health Hospital Group, Grand Rapids, Michigan.

Ibrahim A Ahmed (IA)

Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, Missouri.

Paulo N Anderlini (PN)

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Christopher Bredeson (C)

The Ottawa Hospital Blood and Marrow Transplant Program and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Saurabh Chhabra (S)

Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Christopher E Dandoy (CE)

Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Miguel Angel Diaz (MA)

Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.

Nosha Farhadfar (N)

Division of Hematology and Oncology, College of Medicine, University of Florida, Gainesville, Florida.

Siddhartha Ganguly (S)

Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.

Usama Gergis (U)

Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, New York.

Gregory A Hale (GA)

Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St Petersburg, Florida.

Peiman Hematti (P)

Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.

Rammurti T Kamble (RT)

Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.

Kimberly A Kasow (KA)

Pediatrics, University of North Carolina, Chapel Hill, North Carolina.

Hillard M Lazarus (HM)

Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Jane L Liesveld (JL)

Department of Medicine, Strong Memorial Hospital-University of Rochester Medical Center, Rochester, New York.

Hemant S Murthy (HS)

Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.

Richard F Olsson (RF)

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.

Bipin N Savani (BN)

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Raquel Schears (R)

Department of Emergency Medicine, Mayo Medical School, Rochester, Minnesota.

Sachiko Seo (S)

Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.

Melhern Solh (M)

Northside Hospital Blood and Marrow Transplant and Leukemia Program, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

Thomas Spitzer (T)

Cellular Therapy and Transplantation Laboratory, Massachusetts General Hospital, Boston, Massachusetts.

Amir Steinberg (A)

Mount Sinai Medical Center, New York, New York.

Michele Sugrue (M)

LifeSouth Community Blood Centers, Gainesville, Florida.

Phyllis Warkentin (P)

Nebraska Medicine, Omaha, Nebraska.

John R Wingard (JR)

Division of Hematology and Oncology, College of Medicine, University of Florida, Gainesville, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH